Recent News

• 03.18.2026 - ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board
• 03.04.2026 - ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025
• 02.18.2026 - ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025
• 01.08.2026 - ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
• 01.07.2026 - ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus
• 12.24.2025 - ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®

Recent Filings

• 03.04.2026 - EX-99.1 EX-99.1
• 03.04.2026 - 8-K Current report
• 02.09.2026 - 8-K Current report
• 02.02.2026 - 8-K Current report
• 01.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.08.2026 - EX-99.1 EX-99.1
• 01.08.2026 - 8-K Current report
• 12.29.2025 - 8-K Current report